Home › Cardiovascular Disease › Florida › Deltona
Cardiovascular Disease clinical trials in Deltona, FL
4 studies for Cardiovascular Disease are looking for participants at sites in and around Deltona (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Arrow Clinical Trails, Daytona Beach · 26 mi away
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Hillcrest Medical Research, DeLand · 9 mi away
- University Clinical Research Deland, LLC, DeLand · 9 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Progressive Medical Research, Port Orange · 23 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, DeLand · 9 mi away
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN19 studies
Other studies in Deltona
- Non-Small Cell Lung Cancer15 studies
- Obesity11 studies
- Alzheimer's Disease10 studies
- Overweight9 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Type 2 Diabetes8 studies
- Cancer (all types)7 studies
- Metastatic Cancer5 studies
- Ovarian Cancer5 studies
- Melanoma5 studies
- High Blood Pressure5 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.